Page last updated: 2024-09-03

kf 17837s and Parkinson Disease

kf 17837s has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, K; Jackson, MJ; Jenner, PG; Kanda, T; Kase, H; Koga, K; Kurokawa, M; Kuwana, Y; Ochi, M; Pearce, RK; Shiozaki, S; Smith, LA1
Abe, K; Matsubara, E; Shoji, M1

Reviews

2 review(s) available for kf 17837s and Parkinson Disease

ArticleYear
Antiparkinsonian activity of adenosine A2A antagonists in experimental models.
    Advances in neurology, 1999, Volume: 80

    Topics: Adenosine; Antiparkinson Agents; Humans; Motor Activity; Parkinson Disease; Phenethylamines; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Xanthines

1999
[The treatment of Parkinson's disease--adenosine A2A receptor antagonists].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:1

    Topics: Antiparkinson Agents; Corpus Striatum; Dopamine; Drug Design; Humans; Parkinson Disease; Purinergic P1 Receptor Antagonists; Purines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Xanthines

2002